Inhibitory mechanism of mizoribine on the antibody production of mouse B cells stimulated with lipopolysaccharide

Japanese Journal of Pharmacology

Volumn 74, Issue 4, 1997, Pages 323-330

  Kamada, Hiroyuki ^a   Itoh, Hiromichi ^a   Shibata, Hiroshi ^a   Koshio, Takehiro ^a   Hayashi, Akira ^a   Nakagami, Keiji ^a  

^a ASAHI CHEMICAL INDUSTRY CO   (Japan)

Author keywords

Antibody production; B cell; GTP level; Mizoribine

Indexed keywords

8 AMINOGUANOSINE; GUANOSINE; GUANOSINE TRIPHOSPHATE; IMMUNOGLOBULIN M ANTIBODY; LIPOPOLYSACCHARIDE; MIZORIBINE;

ANIMAL CELL; ANTIBODY PRODUCTION; ARTICLE; B LYMPHOCYTE; CELL CULTURE; CELL PROLIFERATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; MALE; MOUSE; NONHUMAN;

EID: 0030866243     PISSN: 00215198     EISSN: None     Source Type: Journal    
DOI: 10.1254/jjp.74.323     Document Type: Article

References (23)

1. Mizuno K, Tsujino M, Takada M, Hayashi M, Atsumi K, Asano K and Matsuda T: Studies on bredinin: Isolation, characterization and biological properties. J Antibiot (Tokyo) 27, 775-782 (1974)
2. Kamata K, Okubo M, Ishigamori E, Masaki Y, Uchida H, Watanabe K and Kashiwagi N: Immunosuppressive effect of bredinin oh cell-mediated and humoral immune reactions in experimental animals. Transplantation 35, 144-149 (1983)
3. Okubo M, Chen X-M, Kamata K, Masaki Y and Uchiyama T: Suppressive effect of mizoribine on humoral antibody production in DBA/2 mice. Transplantation 41, 495-498 (1986)
4. Tajima A, Hata M, Ohta N, Ohtawara Y, Suzuki K and Aso Y: Bredinin treatment in clinical kidney allografting. Transplantation 38, 116-118 (1984)
5. Aso K, Uchida H, Sato K, Yokota K, Osakabe T, Nakayama Y, Ohkubo M, Kumano K, Endo T, Koshiba K, Watanabe K and Kashiwagi N: Immunosuppression with low-dose cyclosporine combined with bredinin and prednisolone. Transplant Proc 19, 1955-1958 (1987)
6. Osakabe T, Uchida H, Masaki Y, Yokota K, Sato K, Nakayama Y, Ohkubo M, Kumano K, Endo T, Watanabe K and Aso K: Studies on immunosuppression with low-dose cyclosporine combined with mizoribine in experimental and clinical cadaveric renal allotransplantation. Transplant Proc 21, 1598-1600 (1989)
7. Kondo H, Okada J and Kashiwazaki S: Clinical trial of long-term administration of mizoribine in the treatment of lupus nephritis. Clin Immunol 21, 643-650 (1989) (Abstr in English)
8. Shiokawa Y, Honma M, Shichikawa K, Miyamoto T, Hirose J, Nobunaga T, Mizushima Y, Sugawara S, Warabi H, Kondo H and Ogawa N: Clinical effectiveness of mizoribine on rheumatoid arthritis: A double-blind comparative study using lobenzarit disodium as a standard drug. Jpn J Inflamm 11, 375-396 (1991) (Abstr in English)
9. Yata K, Tominaga K, Sone S and Tsubura E: Immunosuppressive effect of 4-carbamoyl-1-β-D-ribofuranosyl imidazolium-5-olate (bredinin) in mice. Tokushima J Exp Med 29, 63-69 (1982)
10. Kamada H, Inamura M, Itoh H, Shibata H and Nakagami K: Distinction of optimum time of suppression between mizoribine and cyclosporin A, and synergetic effect on antibody production in mice. Jpn J Pharmacol 58, Supp I, 122P (1992)
11. Koyama H and Tsuji M: Genetic and biochemical studies on the activation and cytotoxic mechanism of bredinin, a potent inhibitor of purine biosynthesis in mammalian cells. Biochem Pharmacol 32, 3547-3553 (1983)
12. Kusumi T, Tsuda M, Katsunuma T and Yamamura M: Dual inhibitory effect of bredinin. Cell Biochem Funct 7, 201-204 (1988)
13. Sakaguchi K, Tsujino M, Yoshizawa M, Mizuno K and Hayano K: Action of bredinin on mammalian cells. Cancer Res 35, 1643-1648 (1975)
14. Sakaguchi K, Tsujino M, Hayashi M, Kawai K, Mizuno K and Hayano K: Mode of action of bredinin with guanylic acid on L5178Y mouse leukemia cells. J Antibiot (Tokyo) 29, 1320-1327 (1976)
15. Turka LA, Dayton JS, Sinclair G, Thompson CB and Mitchell BS: Guanine ribonucleotide depletion inhibits T cell activation: Mechanism of action of the immunosuppressive drug mizoribine. J Clin Invest 87, 940-948 (1991)
16. Dayton JS, Turka LA, Thompson CB and Mitchell BS: Comparison of the effects of mizoribine with those of azathioprine, 6-mercaptopurine, and mycophenolic acid on T lymphocyte proliferation and purine ribonucleotide metabolism. Mol Pharmacol 41, 671-676 (1992)
17. Mosmann T: Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays. J Immunol Methods 65, 55-63 (1983)
18. Cunningham AJ and Szenberg A: Further improvements in the plaque technique for detecting single antibody forming cells. Immunology 14, 599-600 (1968)
19. Sidi Y and Mitchell BS: 2′-Deoxyguanosine toxicity for B and mature T lymphoid cell lines is mediated by guanine ribonucleotide accumulation. J Clin Invest 74, 1640-1648 (1984)
20. Kazmers I, Mitchell BS, Daddona P, Wotring L, Townsend L and Kelley WN: Inhibition of purine nucleoside phosphorylase by 8-aminoguanosine: Selective toxicity for T lymphoblasts. Science 214, 1137-1139 (1981)
21. Okubo M, Chen X-M, Kamata K, Masaki Y and Uchiyama T: Immunosuppressive effect and mode of action of cyclosporin A (CyA) and mizoribine (MZR) on humoral immune response in mice. Jpn J Nephrol 28, 51-59 (1986) (Abstr in English)
22. Terai C, Hakoda M, Yamanaka H, Kamatani N and Kashiwazaki S: Differential cytotoxic effects of mizoribine and its aglycone on human and murine cells and on normal and enzyme-deficient human cells. Biochem Pharmacol 50, 1099-1102 (1995)
23. Hirohata S and Yanagida T: Inhibition of expression of cyclin A in human B cells by an immunosuppressant mizoribine. J Immunol 155, 5175-5183 (1995)